Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/3828
Title: New oral anticoagulants use in renal disease and af (noacure-af) - where do we stand?: An expert consensus view using the delphi method
Other Titles: Böbrek Hastali?i olan AF Olgularinda non-vitamin K antagonisti oral antikoagülanlarin kullanimi (NOACURE-AF) - Neredeyiz?: Delphi yöntemi kullanan bir uzman uzlaşi raporu
Authors: Arici M.
Ecder T.
Erdinler I.
Ok E.
Özlük Ö.A.
Türk U.Ö.
Alio?lu E.
Keywords: anticoagulant agent
antifibrinolytic agent
antithrombin
warfarin
atrial fibrillation
consensus
Delphi study
human
kidney disease
Review
scientific literature
adverse event
atrial fibrillation
cerebrovascular accident
chronic kidney failure
complication
diabetic complication
heart failure
hemodialysis
hypertension
oral drug administration
risk factor
vascular disease
Administration, Oral
Antifibrinolytic Agents
Antithrombins
Atrial Fibrillation
Consensus
Delphi Technique
Diabetes Complications
Heart Failure
Humans
Hypertension
Kidney Failure, Chronic
Renal Dialysis
Renal Insufficiency, Chronic
Risk Factors
Stroke
Vascular Diseases
Warfarin
Publisher: Turkish Society of Cardiology
Abstract: [No abstract available]
URI: https://doi.org/10.5543/TKDA.2021.40652
https://search.trdizin.gov.tr/yayin/detay/486144
https://hdl.handle.net/20.500.14365/3828
ISSN: 1016-5169
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection

Files in This Item:
File SizeFormat 
2911.pdf370.82 kBAdobe PDFView/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

1
checked on Oct 2, 2024

Page view(s)

54
checked on Sep 30, 2024

Download(s)

14
checked on Sep 30, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.